Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Trastuzumab has changed the prognosis of HER2+ breast cancer. We aimed to investigate the prognosis of ER+/HER2+ patients treated with trastuzumab, thus to guide escalation endocrine treatment in ER+ breast cancer. |